BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10555761)

  • 1. HIT family genes: FHIT but not PKCI-1/HINT produces altered transcripts in colorectal cancer.
    Elnatan J; Murphy D; Goh HS; Smith DR
    Br J Cancer; 1999 Nov; 81(5):874-80. PubMed ID: 10555761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features and FHIT gene expression in sporadic colorectal adenocarcinomas.
    Luceri C; Guglielmi F; De Filippo C; Caderni G; Mini E; Biggeri A; Napoli C; Tonelli F; Cianchi F; Dolara P
    Scand J Gastroenterol; 2000 Jun; 35(6):637-41. PubMed ID: 10912665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of aberrant FHIT transcripts in gastric adenocarcinomas.
    Lee SH; Kim CJ; Park HK; Koh JW; Cho MH; Baek MJ; Lee MS
    Exp Mol Med; 2001 Sep; 33(3):124-30. PubMed ID: 11642547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection.
    Yu HG; Shun LB; Luo HS; Huang H; Yu BP; Yu JP; Meier JJ; Schrader H; Bastian A; Schmitz F; Schmidt WE
    Int J Colorectal Dis; 2002 Nov; 17(6):396-401. PubMed ID: 12355215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant FHIT transcripts in human colorectal cancers.
    Lee SH; Lee SH
    Res Commun Mol Pathol Pharmacol; 2005; 117-118():153-65. PubMed ID: 18426086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant FHIT transcripts in cancerous and corresponding non-cancerous lesions of the digestive tract.
    Chen YJ; Chen PH; Lee MD; Chang JG
    Int J Cancer; 1997 Sep; 72(6):955-8. PubMed ID: 9378557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
    Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C
    Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas.
    Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH
    Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines.
    Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic FHIT analysis in RER+ and RER- adenocarcinomas of the pancreas.
    Hilgers W; Groot Koerkamp B; Geradts J; Tang DJ; Yeo CJ; Hruban RH; Kern SE
    Genes Chromosomes Cancer; 2000 Mar; 27(3):239-43. PubMed ID: 10679912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal transcripts of FHIT gene in thyroid cancer.
    Chang TJ; Tsai TC; Wu YL; Yang HM; Chi CW; Yang AH; Lee CH
    Oncol Rep; 1998; 5(1):245-7. PubMed ID: 9458330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
    Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
    World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
    Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abnormal expression of the FHIT gene in human primary gastrointestinal cancers].
    Duan XM; Zhang GY; Wu ES
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):331-3. PubMed ID: 12205991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer.
    Wierzbicki PM; Adrych K; Kartanowicz D; Dobrowolski S; Stanislawowski M; Chybicki J; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():63-70. PubMed ID: 20083853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer.
    Huiping C; Kristjansdottir S; Bergthorsson JT; Jonasson JG; Magnusson J; Egilsson V; Ingvarsson S
    Eur J Cancer; 2002 Mar; 38(5):728-35. PubMed ID: 11916557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sequence analyses of aberrant FHIT transcripts in gastric cancer cell lines].
    Lee SH; Kim HS
    Korean J Gastroenterol; 2003 Dec; 42(6):476-83. PubMed ID: 14695704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
    Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L
    Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired FHIT expression characterizes serous ovarian carcinoma.
    Ozaki K; Enomoto T; Yoshino K; Fujita M; Buzard GS; Kawano K; Yamasaki M; Murata Y
    Br J Cancer; 2001 Jul; 85(2):247-54. PubMed ID: 11461085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.